Pulmonary Aspergillosis in Cardiac Transplant Patients: The Report of Two Cases.
- Author:
Kook Yang PARK
1
;
Hee Chung KIM
;
Mee Hye OH
;
Suk Keun HONG
;
Ill Sang JUNG
;
Joong Won PARK
;
Do Hyun CHUNG
Author Information
1. Sejong Heart Institute, Sejong General Hospital, Puchon-shi, Korea.
- Publication Type:Case Report
- Keywords:
Heart transplantation;
Aspergillosis
- MeSH:
Amphotericin B;
Antifungal Agents;
Aspergillosis;
Aspergillus;
Aspergillus fumigatus;
Biopsy, Needle;
Diagnosis;
Heart;
Heart Transplantation;
Humans;
Immunity, Cellular;
Itraconazole;
Lung;
Mortality;
Needles;
Pulmonary Aspergillosis*;
Transplantation
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1997;30(3):330-335
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aspergillus Infection is a major cause of mortality in individuals with depressed cell-mediated immunity. Despite therapy with intravenous amphotericin B and oral antifungal agents, high mortality has been reported among heart transplant recipients. We experienced two cases of pulmonary aspergillosis among 15 cases of heart transplantation cases. Both cases were similiar in terms of age, time of diagnosis, diagnosis, and medication. Percutaneous needle aspiration biopsy revealed Aspergillus fumigatus in both cases. The first case showed multiple aspergilloma on both lung fields and were treated by IV Amphotericin B and oral itraconazole. After completion of treatment, the lesion completely disappeared and he has been followed up for more than one year in his good condition. The second case showed a single nodule on his right lower lung field and were treated by both medication and surgery. The patient recovered well and had been doing well until 4th postoperative month when he developed humoral rejection and expired.
